ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1387

Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients

Jens Gert Kuipers1, Michael Koller2, Ulrich Rueffer3, Florian Zeman2, Karolina Mueller4 and Joachim Weis5, 1Clinic for Internal Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3German Fatigue Society, Cologne, Germany, 4Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 5University Clinic Centre Freiburg, Freiburg, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fatigue, patient outcomes, patient-reported outcome measures, quality of life and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Fatigue is a common symptom in patients with rheumatoid arthritis (RA) as well as patients with cancer. Fatigue considerably reduces the quality of life of patients. The present project investigated the prevalence of fatigue in RA patients as compared to cancer patients.

Methods:

The RA study was based on a survey involving a representative, nationwide sample of German physicians specialized in RA and their patients [1]. The patient questionnaire included the EORTC measure of fatigue. Data of cancer patients were taken from the international psychometric validation study of the EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12). Thus, both studies used the same fatigue assessment, allowing for comparative analyses. The EORTC questionnaire assesses five components of fatigue: physical, emotional, cognitive, interference with daily life, and social sequelae. All scores are presented on a linear scale ranging from 0 to 100, with higher scores representing higher symptom burden.

Results:

Data of 708 RA patients (Mean DAS28 2,77, SD 1,20, mean HAQ 0,75 SD 0,70) and 944 cancer patients were available for analysis. Based on clinical considerations with regard to the degree of fatigue, the cohort of cancer patients was divided into four groups: curative therapy (active treatment), palliative treatment, 3 year survivor, 5 years survivor.

N = 1652

Rheumatoid arthritis

Group A

curative therapy

Group B

palliative therapy

Group C

3 years survivors

Group D

5 years survivors

n = 708

n = 311

n = 222

n = 212

n = 199

M

M

M

M

M

Age

59.5

59.5

61.5

57.6

58.3

n

%

n

%

n

%

n

%

n

%

Gender

male

193

27.3

154

49.5

104

46.8

87

41.0

89

44.7

female

514

72.3

157

50.5

118

53.2

125

59.0

110

55.3

M

95% CI

M

95% CI

M

95% CI

M

95% CI

M

95% CI

FA 1

44.4

42.3

46.5

34.5

31.4

37.6

45.9

42.5

49.3

33.9

30.4

37.4

30.7

26.9

34.4

FA 2

26.6

24.5

28.7

26.0

23.0

29.0

36.7

32.7

40.8

21.6

18.0

25.1

19.6

16.0

23.1

FA 3

11.0

9.5

12.4

11.5

9.3

13.8

17.0

14.0

20.1

13.9

10.8

17.0

12.9

9.9

15.9

FA 4

35.3

32.9

37.7

34.6

30.9

28.4

51.4

47.0

55.8

32.4

28.4

36.4

30.5

26.1

34.8

FA 5

20.2

17.9

22.6

9.8

7.5

12.1

10.8

7.6

13.9

15.2

11.6

18.7

13.5

9.8

17.1

FA 1 = physical Fatigue, FA 2 = emotional Fatigue, FA 3 = cognitive Fatigue, FA 4 = interference with daily life, FA 5 = social sequelae. High values in fatigue scores represent high symptom burden.

As shown in Table 1, RA patients suffered from a high level of physical fatigue (M = 44.4; CI 95% 42.3 – 46.5) that was almost identical to the value obtained in palliative care cancer patients. Furthermore, RA patients reported high burden with regard to social consequences (M = 20.2; CI 95% 17.9 – 22.6), more so than all groups of cancer patients (Ms ranging from 9.8 to 15.2). Multiple regression analyses indicated that sex and patient group were significant predictors of all five components of fatigue.

Conclusion:

This study showed that RA patients suffer from a considerable level of fatigue that is comparable to cancer patients.

[1] Kuipers et al.: Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis. Z Rheumatol. 2018 Apr 24. doi: 10.1007/s00393-018-0449-y.)


Disclosure: J. G. Kuipers, None; M. Koller, None; U. Rueffer, None; F. Zeman, None; K. Mueller, None; J. Weis, None.

To cite this abstract in AMA style:

Kuipers JG, Koller M, Rueffer U, Zeman F, Mueller K, Weis J. Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fatigue-in-patients-with-rheumatoid-arthritis-as-compared-to-different-groups-of-cancer-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fatigue-in-patients-with-rheumatoid-arthritis-as-compared-to-different-groups-of-cancer-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology